Company-wide revenue
Reported revenue in 2021 ¥7.72B Reported revenue in 2025 ¥10.01B
- growth amount
- +¥2.29B
- growth annualized
- +6.7%
- growth total
- +29.7%
Japanese company profile · 9221
Furuhashi EPO
In its FY2025 public filing, Furuhashi EPO reports Biomaterials business, Resource recycling. The page shows business-level revenue and profit where the source disclosures support comparison.
Romanized spelling of the Japanese company name; not an official English name.
Original Japanese company name: フルハシＥＰＯ株式会社
Reported company-wide figures
What does this company do?
What does this company do?
Furuhashi EPO's largest reported business by revenue in FY2025 was Biomaterials business.
The business with the highest reported segment profit in FY2025 was Biomaterials business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Biomaterials business | ¥7.34B ↗ | 73.3% | ¥1.06B ↗ |
| Resource recycling | ¥1.7B ↗ | 17.0% | ¥89.87M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Biomaterials business
- バイオマテリアル事業
- Resource recycling
- 資源循環事業
- Business label unavailable in English
- 環境物流事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Biomaterials business
- バイオマテリアル事業
- Resource recycling
- 資源循環事業
- Business label unavailable in English
- 環境物流事業
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Biomaterials business
Reported revenue in 2021 ¥5.4B Reported revenue in 2025 ¥7.34B
- growth amount
- +¥1.93B
- growth annualized
- +7.9%
- growth total
- +35.7%
View original filing
Resource recycling
Reported revenue in 2021 ¥1.46B Reported revenue in 2025 ¥1.7B
- growth amount
- +¥237.69M
- growth annualized
- +3.8%
- growth total
- +16.3%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YBWO
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.